Calyx Chemicals & Pharmaceuticals Ltd.

Calyx Chemicals & Pharmaceuticals Ltd. (India) holds 19 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 19 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Calyx Chemicals & Pharmaceuticals Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/calyx-chemicals-and-pharmaceuticals-ltd

Overview

Calyx Chemicals & Pharmaceuticals Ltd. is a pharmaceutical company headquartered in Vashi, India.

Active ingredients with DMF or CEP filings

Substances for which Calyx Chemicals & Pharmaceuticals Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Calyx Chemicals & Pharmaceuticals Ltd. holds 19 active (20 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ESZOPICLONEActive2023-12-15
  • AZITHROMYCIN DIHYDRATEActive2022-11-22
  • AZAERYTHROMYCINActive2018-07-31
  • MECLIZINE HYDROCHLORIDEActive2015-04-29
  • AZITHROMYCIN MONOHYDRATEActive2013-09-21
  • VALGANCICLOVIR HYDROCHLORIDEActive2012-11-28
  • IRBESARTANActive2010-07-26
  • HYDROXYZINE HYDROCHLORIDEActive2010-07-22
  • ARTEMETHERActive2010-07-09
  • LUMEFANTRINEActive2010-07-09
  • FLUCYTOSINEActive2010-01-22
  • ERYTHROMYCIN STEARATEActive2008-10-06
  • LOSARTAN POTASSIUM USPActive2008-08-27
  • CETIRIZINE HYDROCHLORIDEActive2008-03-06
  • ISONIAZIDActive2008-02-07
  • ERYTHROMYCIN ESTOLATEActive2007-03-28
  • ERYTHROMYCINActive2006-12-14
  • PYRAZINAMIDE USPActive2001-07-31
  • ZOPICLONE E.P.Active2001-06-22
  • VALPROIC ACIDInactive2008-09-12

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Calyx Chemicals & Pharmaceuticals Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Calyx Chemicals & Pharmaceuticals Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Calyx Chemicals & Pharmaceuticals Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.